CREDIT SUISSE AG/

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
3/31/2024	0%	+0%	$886K	180K	+8,141	+4.73%	$4.92	Q1 2024
12/31/2023	0%	+0%	$1.51M	172K	+31,392	+22.3%	$8.79	Q4 2023
9/30/2023	0%	0%	$1.61M	141K	-1,573	-1.11%	$11.47	Q3 2023
6/30/2023	0%	+0%	$3.6M	142K	+3,342	+2.41%	$25.31	Q2 2023
3/31/2023	0%	+0%	$4.47M	139K	+8,841	+6.8%	$32.21	Q1 2023
12/31/2022	0%	+0%	$2.4M	130K	+32,752	+33.7%	$18.46	Q4 2022
9/30/2022	0%	+0%	$2.63M	97.3K	+6,376	+7.02%	$26.99	Q3 2022
6/30/2022	0%	+0%	$1.26M	90.9K	+231	+0.25%	$13.81	Q2 2022
3/31/2022	0%	+0%	$1.77M	90.6K	+5,676	+6.68%	$19.49	Q1 2022
12/31/2021	0%	0%	$1.39M	85K	-1,086	-1.26%	$16.32	Q4 2021
9/30/2021	0%	+0%	$2.4M	86.1K	+3,814	+4.64%	$27.87	Q3 2021
6/30/2021			$2K	53			$37.74^*	Q2 2021
6/30/2021	0%	0%	$2.44M	82.2K	-3,641	-4.24%	$29.64	Q2 2021
3/31/2021			$1K	19			$52.63^*	Q1 2021
3/31/2021	0%	0%	$2.4M	85.9K	-21,563	-20.1%	$27.94	Q1 2021
12/31/2020			$2K	54			$37.04^*	Q4 2020
12/31/2020	0%	+0%	$3.05M	107K	+51,055	+90.5%	$28.34	Q4 2020
9/30/2020	0%	+0%	$1.42M	56.4K	+6,928	+14%	$25.15	Q3 2020
6/30/2020	0%	0%	$1.21M	49.5K	-10,077	-16.9%	$24.42	Q2 2020
3/31/2020	0%	+0%	$881K	59.5K	+24,528	+70.1%	$14.80	Q1 2020
12/31/2019	0%	+0%	$568K	35K	+7,990	+29.6%	$16.22	Q4 2019
9/30/2019	0%	0%	$352K	27K	-1,959	-6.76%	$13.03	Q3 2019
6/30/2019	0%	+0%	$376K	29K	+5,352	+22.7%	$12.97	Q2 2019
3/31/2019	0%	+0%	$373K	23.6K	+3,849	+19.5%	$15.79	Q1 2019
12/31/2018	0%	+0%	$398K	19.8K	+2,462	+14.2%	$20.12	Q4 2018
9/30/2018	0%	0%	$431K	17.3K	-7,491	-30.2%	$24.89	Q3 2018
6/30/2018	0%	0%	$682K	24.8K	-766	-3%	$27.49	Q2 2018
3/31/2018	0%	0%	$788K	25.6K	-2,491	-8.88%	$30.81	Q1 2018
12/31/2017	0%	+0%	$1M	28.1K	+3,693	+15.2%	$35.70	Q4 2017
9/30/2017	0%	+0%	$670K	24.4K	+11,769	+93.4%	$27.49	Q3 2017
6/30/2017	0%	0%	$332K	12.6K	-560	-4.25%	$26.34	Q2 2017
3/31/2017	0%	0%	$274K	13.2K	-4,879	-27%	$20.81	Q1 2017
12/31/2016			$1K	35			$28.57^*	Q4 2016
12/31/2016	0%	0%	$373K	18K	-4,843	-21.2%	$20.67	Q4 2016
9/30/2016	0%	0%	$371K	22.9K	-1,966	-7.91%	$16.21	Q3 2016
6/30/2016	0%	0%	$338K	24.9K	-14,431	-36.7%	$13.60	Q2 2016
3/31/2016	0%	+0%	$685K	39.3K	+22,477	+134%	$17.44	Q1 2016
12/31/2015	0%	+0%	$574K	16.8K	+2,345	+16.2%	$34.15	Q4 2015
9/30/2015	0%	0%	$430K	14.5K	-22,637	-61%	$29.74	Q3 2015
6/30/2015	0%	+0%	$1.19M	37.1K	+11,618	+45.6%	$31.97	Q2 2015
3/31/2015	0%	0%	$529K	25.5K	-11,908	-31.8%	$20.76	Q1 2015
12/31/2014	0%	+0%	$633K	37.4K	+18,940	+103%	$16.93	Q4 2014
9/30/2014	0%	+0%	$357K	18.4K	+11,382	+161%	$19.35	Q3 2014
6/30/2014	0%	+0%	$240K	7.07K	+7,066	NEW	$33.97	Q2 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.